Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection

Journal of Infectious Diseases

Volumn 194, Issue 9, 2006, Pages 1258-1266

  Olsen, Anja Weinreich ^a   Follmann, Frank ^a   Jensen, Klaus ^a   Højrup, Peter ^c   Leah, Robert ^a,d   Sørensen, Hanne ^b   Hoffmann, Steen ^c   Andersen, Peter ^a   Theisen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Unizyme Laboratories A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PEPTIDE 5; PROTEIN CT043; PROTEIN CT511; PROTEIN CT521; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL HETEROGENEITY; CELL LYSATE; CHLAMYDIA TRACHOMATIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SEROTYPE; TARGET CELL; TH1 CELL; UROGENITAL TRACT INFECTION;

ADULT; ANTIGENS, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EPITOPES, T-LYMPHOCYTE; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; TH1 CELLS;

EID: 33750296372     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/508203     Document Type: Article

References (46)

1. World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva, Switzerland: WHO, 2001.
2. Pearlman MD, Mcneeley SG. A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections. Obstet Gynecol Surv 1992; 47:448-61.
3. Peipert JF. Clinical practice: genital chlamydial infections. N Engl J Med 2003; 349:2424-30.
4. Brunham RC. Human immunity to Chlamydiae. In: Stephens RN, ed. Chlamydia intracellular biology, pathogenesis, and immunity. Washington, DC: American Society for Microbiology Press, 1999:211-38.
5. Kelly KA. Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms. Int Rev Immunol 2003; 22:3-41.
6. Reddy BS, Rastogi S, Das B, Salhan S, Verma S, Mittal A. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses. Clin Exp Immunol 2004; 137:552-8.
7. Arno JN, Ricker VA, Batteiger BE, Katz BP, Caine VA, Jones RB. Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J Infect Dis 1990; 162:1385-9.
8. Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 2005; 142:548-54.
9. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-γ. J Infect Dis 2005; 192:591-9.
10. Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis 2005; 191:1084-92.
11. Hawkins RA, Rank RG, Kelly KA. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect Immun 2002;70:5132-9.
12. Igietseme IU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol 1993; 5:317-24.
13. Johansson M, Schon K, Ward M, Lycke N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 1997;65:1032-44.
14. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002;70:2741-51.
15. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995;63:4661-8.
16. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 1997; 158:3344-52.
17. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia tradiomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90:3998-4002.
18. Morrison RP. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect Immun 2000; 68: 6038-40.
19. Perry LL, Su H, Feilzer K, et al. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 1999; 162:3541-8.
20. Kim SK, Angevine M, Demick K, et al. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J Immunol 1999; 162:6855-66.
21. Kim SK, Devine L, Angevine M, Demars R, Kavathas PB. Direct detection and magnetic isolation of Chlamydia trachomatis major outer membrane protein-specific CD8+ CTLs with HLA class I tetramers. J Immunol 2000; 165:7285-92.
22. Ortiz L, Angevine M, Kim SK, Watkins D, Demars R. T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infect Immun 2000; 68:1719-23.
23. Ortiz L, Demick KP, Petersen JW, et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol 1996; 157:4554-67.
24. Deane KH, Jecock RM, Pearce JH, Gaston JS. Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. Clin Exp Immunol 1997; 109:439-45.
25. Gaston JS, Deane KH, Jecock RM, Pearce JH. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol 1996; 23:130-6.
26. Gervassi AL, Grabstein KH, Probst P, Hess B, Alderson MR, Fling SP. Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis. J Immunol 2004; 173:6905-13.
27. Goodall JC, Beacock-Sharp H, Deane KH, Gaston JS. Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4+ T cells from humans infected with Chlamydia trachomatis. Clin Exp Immunol 2001; 126:488-93.
28. Goodall JC, Yeo G, Huang M, Raggiaschi R, Gaston JS. Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. Eur J Immunol 2001; 31:1513-22.
29. Andersen P, Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993; 61:844-51.
30. Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987; 8:93-9.
31. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68:850-8.
32. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282:754-9.
33. Franken KL, Hiemstra HS, Van Meijgaarden KE, et al. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 2000; 18:95-9.
34. Theisen M, Vuust J, Gottschau A, Jepsen S, Hogh B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol 1995; 2:30-4.
35. Theisen M, Soe S, Jessing Sg, et al. Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine 2000; 19:204-12.
36. Hassell AB, Reynolds DJ, Deacon M, Gaston JS, Pearce JH. Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones. Immunology 1993; 79:513-9.
37. Skipp P, Robinson J, O'connor CD, Clarke IN. Shotgun proteomic analysis of Chlamydia trachomatis. Proteomics 2005; 5:1558-73.
38. Baloglu S, Boyle SM, Vemulapalli R, Sriranganathan N, Schurig GG, Toth TE. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein. Vet Microbiol 2005; 109:11-7.
39. Iborra S, Soto M, Carrion J, et al. The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice. Infect Immun 2003; 71:6562-72.
40. Jomaa M, Kyd JM, Cripps AW. Mucosal immunisation with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model. FEMS Immunol Med Microbiol 2005; 44:59-67.
41. Kinnunen A, Paavonen J, Surcel HM. Heat shock protein 60 specific T-cell response in chlamydial infections. Scand J Immunol 2001; 54:76-81.
42. Clad A, Petersen EE, Dettlaff S. Antibodies to Chlamydia trachomatis heat shock protein 60 (cHSP60) and Chlamydia trachomatis major outer membrane protein (MOMP) in women with different tubal status. Clin Lab 2003; 49:269-71.
43. Schuppe HC, Pichlmeier U, Schenk BI, Bottcher M. Antibodies to Chlamydia trachomatis heat shock protein (cHSP60) and major outer membrane protein (MOMP) in men with impaired fertility. Clin Lab 2003; 49:273-5.
44. Sziller I, Witkin SS, Ziegert M, Csapo Z, Ujhazy A, Papp Z. Serological responses of patients with ectopic pregnancy to epitopes of the Chlamydia trachomatis 60 kDa heat shock protein. Hum Reprod 1998; 13:1088-93.
45. Wagar EA, Schachter J, Bavoil P, Stephens RS. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis 1990; 162:922-7.
46. Van Der Most RG, Murali-Krishna K, Lanier JG, et al. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 2003; 315:93-102.